Retatrutide: Breakthrough in Peptide Research for Weight Loss and Metabolic Disorders Retatrutide is regarded worldwide as the promising successor to Mounjaro (Tirzepatide), and this is well supported by scientific evidence. While Tirzepatide is a dual receptor agonist (GLP-1 and GIP),…